Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | ACMSD | Q8TDX5 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | ABCC1 | P33527 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | CA6 | P23280 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16192624 | 0.88 | NPC1 (0.39) | ALDH1A1KDM4EABCC1LMNAGAA | |
| SCHEMBL27969724 | 0.85 | AKR1C3 (0.44) | ALDH1A1LMNAGAAKMT2ASMN1; SMN2 | |
| SCHEMBL14905781 | 0.85 | TP53 (0.46) | ALDH1A1KDM4ELMNAHSD17B10KMT2A | |
| SCHEMBL29391340 | 0.85 | ALDH1A1 (0.40) | ALDH1A1ALOX15KDM4ELMNAGAA | |
| Ethylene SCHEMBL854799 | 0.82 | ALDH1A1 (0.38) | ALDH1A1ALOX15KDM4ELMNAGAA | |
| SCHEMBL6391942 | 0.82 | ALDH1A1 (0.40) | ALDH1A1ALOX15ACMSDKDM4EABCC1 | |
| Ethylene Glycol SCHEMBL27971696 | 0.80 | ALDH1A1 (0.39) | ALDH1A1ALOX15KDM4ELMNAKMT2A | |
| SCHEMBL1315359 | 0.79 | ROCK2 (0.35) | ALDH1A1ALOX15KDM4ELMNAHSD17B10 | |
| SCHEMBL25272274 | 0.79 | KMO (0.43) | ALDH1A1ACMSDKDM4EHSD17B10GAA | |
| SCHEMBL16192625 | 0.77 | AKR1C3 (0.40) | ALDH1A1LMNAGAAKMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4441017-A1 | OLIGOMERIZATION PROCESS | Shell Internationale Research Maatschappij B.V. (NL) | 2024-10-09 | — | — | EP | disclosed |
| CN-118382606-A | Oligomerization process | 国际壳牌研究有限公司 | 2024-07-23 | — | — | CN | disclosed |
| WO-2023101667-A1 | OLIGOMERIZATION PROCESS | SHELL OIL COMAPNY (US) | 2023-06-08 | — | — | WO | disclosed |
| EP-1409439-B1 | A PROCESS FOR THE ISOMERIZATION OF AN OLEFIN | SHELL INT RESEARCH (NL) | 2015-04-15 | — | — | EP | disclosed |
| EP-1385891-B1 | Process for preparing a nickel-containing ethylene oligomerization catalyst and use thereof | SHELL INT RESEARCH (NL) | 2012-10-24 | — | — | EP | disclosed |
| EP-1414773-B1 | A PROCESS FOR THE ISOMERIZATION OF A VINYLIDENE OLEFIN | SHELL INT RESEARCH (NL) | 2007-10-03 | — | — | EP | disclosed |
| US-20060183954-A1 | Process for the isomerization of an olefin | DOLL MICHAEL J | 2006-08-17 | — | — | US | disclosed |
| US-7078579-B2 | Process for the isomerization of a vinylidene olefin | SHELL OIL COMPANY (US) | 2006-07-18 | — | — | US | disclosed |
| US-7041865-B2 | Process for the isomerization of an olefin | SHELL OIL COMPANY (US) | 2006-05-09 | — | — | US | disclosed |
| US-20050049447-A1 | Nickel-containing ethylene oligomerization catalyst and use thereof | BROWN DAVID STEPHEN (US) | 2005-03-03 | — | — | US | disclosed |
| US-20020173685-A1 | Nickel-containing ethylene oligomerization catalyst and use thereof | SHELL OIL COMPANY | 2002-11-21 | — | — | US | disclosed |
| WO-2002083750-A2 | NICKEL-CONTAINING ETHYLENE OLIGOMERIZATION CATALYST AND USE THEREOF | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2002-10-24 | — | — | WO | disclosed |
| US-4317936-A | CATIONIC OR ANIONIC ION EXCHANGE RESINS MODIFIED BY A GROUP 8 METAL AND A HETRATOM-CONTAINING COMPOUND | SHELL OIL COMPANY (US) | 1982-03-02 | — | — | US | disclosed |
| US-4306085-A | Hydroformylation process using resin-ligand-metal catalyst | SHELL OIL COMPANY (US) | 1981-12-15 | — | — | US | disclosed |
| EP-0005569-B1 | RESIN-LIGAND-TRANSITION METAL COMPLEX COMPOSITION AND PROCESSES FOR USING THIS COMPOSITION AS CATALYST | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1981-11-04 | — | — | EP | disclosed |
| EP-0002557-B1 | RESIN-LIGAND TRANSITION METAL COMPLEX COMPOSITION AND PROCESSES FOR USING THIS COMPOSITION AS CATALYST | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1981-09-23 | — | — | EP | disclosed |
| US-4284835-A | METAL COMPLEX CATALYST BOUND TO RESIN | SHELL OIL COMPANY (US) | 1981-08-18 | — | — | US | disclosed |
| US-4266085-A | Olefin disproportionation process | SHELL OIL COMPANY (US) | 1981-05-05 | — | — | US | disclosed |
| US-4179402-A | Resin-metal-ligand composition | SHELL OIL COMPANY (US) | 1979-12-18 | — | — | US | disclosed |
| US-4179403-A | Resin-ligand-metal complex compositions | SHELL OIL COMPANY (US) | 1979-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020173685-A1 | Nickel-containing ethylene oligomerization catalyst and use thereof | POF1B, FOSB, PPIP5K2 | ALDH1A1 4481/4885ALOX15 161/4885ACMSD 1771/4885 |
| US-20050049447-A1 | Nickel-containing ethylene oligomerization catalyst and use thereof | POF1B, FOSB, PPIP5K2 | ALDH1A1 4481/4885ALOX15 161/4885ACMSD 1771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.